Global Contract Pharmaceutical Manufacturing Market Insights, Forecast to 2026
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and so on, which required for pharmaceutical manufacturing. The main type of contract pharmaceutical manufacturing is API and FDF.
The contract pharmaceutical manufacturing industry is not very concentrated the revenue of top eighteenth manufacturers account about 22% of global revenue.
In the world wide, the major manufactures mainly distribute in North America and Europe. The transnational companies, like Catalent and DPx, are the leading manufactures in the World.
North America and Europe is the industry's leading region. In 2015, the revenue of contract pharmaceutical manufacturing is about 19 billion USD in North America; its proportion of total global revenue exceeds 32%. In 2015, the revenue is about 14 billion USD in Europe. Japan and India have witnessed a major chunk developing of the contract pharmaceutical manufacturing in the Asia region. Especially India, its revenue is 8 billion USD in 2015.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Contract Pharmaceutical Manufacturing 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Contract Pharmaceutical Manufacturing 3900 industry.
Based on our recent survey, we have several different scenarios about the Contract Pharmaceutical Manufacturing 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 77540 million in 2019. The market size of Contract Pharmaceutical Manufacturing 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Contract Pharmaceutical Manufacturing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Contract Pharmaceutical Manufacturing market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Contract Pharmaceutical Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Contract Pharmaceutical Manufacturing market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Contract Pharmaceutical Manufacturing market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Contract Pharmaceutical Manufacturing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Contract Pharmaceutical Manufacturing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Contract Pharmaceutical Manufacturing market.
The following manufacturers are covered in this report:
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and so on, which required for pharmaceutical manufacturing. The main type of contract pharmaceutical manufacturing is API and FDF.
The contract pharmaceutical manufacturing industry is not very concentrated the revenue of top eighteenth manufacturers account about 22% of global revenue.
In the world wide, the major manufactures mainly distribute in North America and Europe. The transnational companies, like Catalent and DPx, are the leading manufactures in the World.
North America and Europe is the industry's leading region. In 2015, the revenue of contract pharmaceutical manufacturing is about 19 billion USD in North America; its proportion of total global revenue exceeds 32%. In 2015, the revenue is about 14 billion USD in Europe. Japan and India have witnessed a major chunk developing of the contract pharmaceutical manufacturing in the Asia region. Especially India, its revenue is 8 billion USD in 2015.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Contract Pharmaceutical Manufacturing 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Contract Pharmaceutical Manufacturing 3900 industry.
Based on our recent survey, we have several different scenarios about the Contract Pharmaceutical Manufacturing 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 77540 million in 2019. The market size of Contract Pharmaceutical Manufacturing 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Contract Pharmaceutical Manufacturing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Contract Pharmaceutical Manufacturing market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Contract Pharmaceutical Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Contract Pharmaceutical Manufacturing market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Contract Pharmaceutical Manufacturing market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Contract Pharmaceutical Manufacturing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Contract Pharmaceutical Manufacturing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Contract Pharmaceutical Manufacturing market.
The following manufacturers are covered in this report:
- Catalent
- DPx
- Lonza
- Piramal Healthcare
- Aenova
- Jubilant
- Famar
- Boehringer Ingelheim
- Fareva Holding
- AbbVie
- Nipro Corp
- Vetter
- Sopharma
- DPT Laboratories
- Recipharm
- NextPharma
- Dishman
- Aesica
- API
- FDF
- Specialty/Midsize
- Generics
- Big Pharma
- Other
1 STUDY COVERAGE
1.1 Contract Pharmaceutical Manufacturing Product Introduction
1.2 Market Segments
1.3 Key Contract Pharmaceutical Manufacturing Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Type
1.4.2 API
1.4.3 FDF
1.5 Market by Application
1.5.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Application
1.5.2 Specialty/Midsize
1.5.3 Generics
1.5.4 Big Pharma
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Contract Pharmaceutical Manufacturing Industry Impact
1.6.1 How the Covid-19 is Affecting the Contract Pharmaceutical Manufacturing Industry
1.6.1.1 Contract Pharmaceutical Manufacturing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Contract Pharmaceutical Manufacturing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Contract Pharmaceutical Manufacturing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Contract Pharmaceutical Manufacturing Market Size Estimates and Forecasts
2.1.1 Global Contract Pharmaceutical Manufacturing Revenue 2015-2026
2.1.2 Global Contract Pharmaceutical Manufacturing Sales 2015-2026
2.2 Contract Pharmaceutical Manufacturing Market Size by Region: 2020 Versus 2026
2.2.1 Global Contract Pharmaceutical Manufacturing Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Contract Pharmaceutical Manufacturing Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL CONTRACT PHARMACEUTICAL MANUFACTURING COMPETITOR LANDSCAPE BY PLAYERS
3.1 Contract Pharmaceutical Manufacturing Sales by Manufacturers
3.1.1 Contract Pharmaceutical Manufacturing Sales by Manufacturers (2015-2020)
3.1.2 Contract Pharmaceutical Manufacturing Sales Market Share by Manufacturers (2015-2020)
3.2 Contract Pharmaceutical Manufacturing Revenue by Manufacturers
3.2.1 Contract Pharmaceutical Manufacturing Revenue by Manufacturers (2015-2020)
3.2.2 Contract Pharmaceutical Manufacturing Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Contract Pharmaceutical Manufacturing Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Contract Pharmaceutical Manufacturing Revenue in 2019
3.2.5 Global Contract Pharmaceutical Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Contract Pharmaceutical Manufacturing Price by Manufacturers
3.4 Contract Pharmaceutical Manufacturing Manufacturing Base Distribution, Product Types
3.4.1 Contract Pharmaceutical Manufacturing Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Contract Pharmaceutical Manufacturing Product Type
3.4.3 Date of International Manufacturers Enter into Contract Pharmaceutical Manufacturing Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Contract Pharmaceutical Manufacturing Market Size by Type (2015-2020)
4.1.1 Global Contract Pharmaceutical Manufacturing Sales by Type (2015-2020)
4.1.2 Global Contract Pharmaceutical Manufacturing Revenue by Type (2015-2020)
4.1.3 Contract Pharmaceutical Manufacturing Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Contract Pharmaceutical Manufacturing Market Size Forecast by Type (2021-2026)
4.2.1 Global Contract Pharmaceutical Manufacturing Sales Forecast by Type (2021-2026)
4.2.2 Global Contract Pharmaceutical Manufacturing Revenue Forecast by Type (2021-2026)
4.2.3 Contract Pharmaceutical Manufacturing Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Contract Pharmaceutical Manufacturing Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Contract Pharmaceutical Manufacturing Market Size by Application (2015-2020)
5.1.1 Global Contract Pharmaceutical Manufacturing Sales by Application (2015-2020)
5.1.2 Global Contract Pharmaceutical Manufacturing Revenue by Application (2015-2020)
5.1.3 Contract Pharmaceutical Manufacturing Price by Application (2015-2020)
5.2 Contract Pharmaceutical Manufacturing Market Size Forecast by Application (2021-2026)
5.2.1 Global Contract Pharmaceutical Manufacturing Sales Forecast by Application (2021-2026)
5.2.2 Global Contract Pharmaceutical Manufacturing Revenue Forecast by Application (2021-2026)
5.2.3 Global Contract Pharmaceutical Manufacturing Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Contract Pharmaceutical Manufacturing by Country
6.1.1 North America Contract Pharmaceutical Manufacturing Sales by Country
6.1.2 North America Contract Pharmaceutical Manufacturing Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Contract Pharmaceutical Manufacturing Market Facts & Figures by Type
6.3 North America Contract Pharmaceutical Manufacturing Market Facts & Figures by Application
7 EUROPE
7.1 Europe Contract Pharmaceutical Manufacturing by Country
7.1.1 Europe Contract Pharmaceutical Manufacturing Sales by Country
7.1.2 Europe Contract Pharmaceutical Manufacturing Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Contract Pharmaceutical Manufacturing Market Facts & Figures by Type
7.3 Europe Contract Pharmaceutical Manufacturing Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Contract Pharmaceutical Manufacturing by Region
8.1.1 Asia Pacific Contract Pharmaceutical Manufacturing Sales by Region
8.1.2 Asia Pacific Contract Pharmaceutical Manufacturing Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Contract Pharmaceutical Manufacturing Market Facts & Figures by Type
8.3 Asia Pacific Contract Pharmaceutical Manufacturing Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Contract Pharmaceutical Manufacturing by Country
9.1.1 Latin America Contract Pharmaceutical Manufacturing Sales by Country
9.1.2 Latin America Contract Pharmaceutical Manufacturing Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Contract Pharmaceutical Manufacturing Market Facts & Figures by Type
9.3 Central & South America Contract Pharmaceutical Manufacturing Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Contract Pharmaceutical Manufacturing by Country
10.1.1 Middle East and Africa Contract Pharmaceutical Manufacturing Sales by Country
10.1.2 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Contract Pharmaceutical Manufacturing Market Facts & Figures by Type
10.3 Middle East and Africa Contract Pharmaceutical Manufacturing Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Catalent
11.1.1 Catalent Corporation Information
11.1.2 Catalent Description, Business Overview and Total Revenue
11.1.3 Catalent Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Catalent Contract Pharmaceutical Manufacturing Products Offered
11.1.5 Catalent Recent Development
11.2 DPx
11.2.1 DPx Corporation Information
11.2.2 DPx Description, Business Overview and Total Revenue
11.2.3 DPx Sales, Revenue and Gross Margin (2015-2020)
11.2.4 DPx Contract Pharmaceutical Manufacturing Products Offered
11.2.5 DPx Recent Development
11.3 Lonza
11.3.1 Lonza Corporation Information
11.3.2 Lonza Description, Business Overview and Total Revenue
11.3.3 Lonza Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Lonza Contract Pharmaceutical Manufacturing Products Offered
11.3.5 Lonza Recent Development
11.4 Piramal Healthcare
11.4.1 Piramal Healthcare Corporation Information
11.4.2 Piramal Healthcare Description, Business Overview and Total Revenue
11.4.3 Piramal Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Piramal Healthcare Contract Pharmaceutical Manufacturing Products Offered
11.4.5 Piramal Healthcare Recent Development
11.5 Aenova
11.5.1 Aenova Corporation Information
11.5.2 Aenova Description, Business Overview and Total Revenue
11.5.3 Aenova Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Aenova Contract Pharmaceutical Manufacturing Products Offered
11.5.5 Aenova Recent Development
11.6 Jubilant
11.6.1 Jubilant Corporation Information
11.6.2 Jubilant Description, Business Overview and Total Revenue
11.6.3 Jubilant Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Jubilant Contract Pharmaceutical Manufacturing Products Offered
11.6.5 Jubilant Recent Development
11.7 Famar
11.7.1 Famar Corporation Information
11.7.2 Famar Description, Business Overview and Total Revenue
11.7.3 Famar Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Famar Contract Pharmaceutical Manufacturing Products Offered
11.7.5 Famar Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Corporation Information
11.8.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.8.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Products Offered
11.8.5 Boehringer Ingelheim Recent Development
11.9 Fareva Holding
11.9.1 Fareva Holding Corporation Information
11.9.2 Fareva Holding Description, Business Overview and Total Revenue
11.9.3 Fareva Holding Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Fareva Holding Contract Pharmaceutical Manufacturing Products Offered
11.9.5 Fareva Holding Recent Development
11.10 AbbVie
11.10.1 AbbVie Corporation Information
11.10.2 AbbVie Description, Business Overview and Total Revenue
11.10.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.10.4 AbbVie Contract Pharmaceutical Manufacturing Products Offered
11.10.5 AbbVie Recent Development
11.1 Catalent
11.1.1 Catalent Corporation Information
11.1.2 Catalent Description, Business Overview and Total Revenue
11.1.3 Catalent Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Catalent Contract Pharmaceutical Manufacturing Products Offered
11.1.5 Catalent Recent Development
11.12 Vetter
11.12.1 Vetter Corporation Information
11.12.2 Vetter Description, Business Overview and Total Revenue
11.12.3 Vetter Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Vetter Products Offered
11.12.5 Vetter Recent Development
11.13 Sopharma
11.13.1 Sopharma Corporation Information
11.13.2 Sopharma Description, Business Overview and Total Revenue
11.13.3 Sopharma Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Sopharma Products Offered
11.13.5 Sopharma Recent Development
11.14 DPT Laboratories
11.14.1 DPT Laboratories Corporation Information
11.14.2 DPT Laboratories Description, Business Overview and Total Revenue
11.14.3 DPT Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.14.4 DPT Laboratories Products Offered
11.14.5 DPT Laboratories Recent Development
11.15 Recipharm
11.15.1 Recipharm Corporation Information
11.15.2 Recipharm Description, Business Overview and Total Revenue
11.15.3 Recipharm Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Recipharm Products Offered
11.15.5 Recipharm Recent Development
11.16 NextPharma
11.16.1 NextPharma Corporation Information
11.16.2 NextPharma Description, Business Overview and Total Revenue
11.16.3 NextPharma Sales, Revenue and Gross Margin (2015-2020)
11.16.4 NextPharma Products Offered
11.16.5 NextPharma Recent Development
11.17 Dishman
11.17.1 Dishman Corporation Information
11.17.2 Dishman Description, Business Overview and Total Revenue
11.17.3 Dishman Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Dishman Products Offered
11.17.5 Dishman Recent Development
11.18 Aesica
11.18.1 Aesica Corporation Information
11.18.2 Aesica Description, Business Overview and Total Revenue
11.18.3 Aesica Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Aesica Products Offered
11.18.5 Aesica Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Contract Pharmaceutical Manufacturing Market Estimates and Projections by Region
12.1.1 Global Contract Pharmaceutical Manufacturing Sales Forecast by Regions 2021-2026
12.1.2 Global Contract Pharmaceutical Manufacturing Revenue Forecast by Regions 2021-2026
12.2 North America Contract Pharmaceutical Manufacturing Market Size Forecast (2021-2026)
12.2.1 North America: Contract Pharmaceutical Manufacturing Sales Forecast (2021-2026)
12.2.2 North America: Contract Pharmaceutical Manufacturing Revenue Forecast (2021-2026)
12.2.3 North America: Contract Pharmaceutical Manufacturing Market Size Forecast by Country (2021-2026)
12.3 Europe Contract Pharmaceutical Manufacturing Market Size Forecast (2021-2026)
12.3.1 Europe: Contract Pharmaceutical Manufacturing Sales Forecast (2021-2026)
12.3.2 Europe: Contract Pharmaceutical Manufacturing Revenue Forecast (2021-2026)
12.3.3 Europe: Contract Pharmaceutical Manufacturing Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Contract Pharmaceutical Manufacturing Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Contract Pharmaceutical Manufacturing Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Contract Pharmaceutical Manufacturing Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Contract Pharmaceutical Manufacturing Market Size Forecast by Region (2021-2026)
12.5 Latin America Contract Pharmaceutical Manufacturing Market Size Forecast (2021-2026)
12.5.1 Latin America: Contract Pharmaceutical Manufacturing Sales Forecast (2021-2026)
12.5.2 Latin America: Contract Pharmaceutical Manufacturing Revenue Forecast (2021-2026)
12.5.3 Latin America: Contract Pharmaceutical Manufacturing Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Contract Pharmaceutical Manufacturing Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Contract Pharmaceutical Manufacturing Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Contract Pharmaceutical Manufacturing Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Contract Pharmaceutical Manufacturing Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Contract Pharmaceutical Manufacturing Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Contract Pharmaceutical Manufacturing Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Contract Pharmaceutical Manufacturing Product Introduction
1.2 Market Segments
1.3 Key Contract Pharmaceutical Manufacturing Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Type
1.4.2 API
1.4.3 FDF
1.5 Market by Application
1.5.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Application
1.5.2 Specialty/Midsize
1.5.3 Generics
1.5.4 Big Pharma
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Contract Pharmaceutical Manufacturing Industry Impact
1.6.1 How the Covid-19 is Affecting the Contract Pharmaceutical Manufacturing Industry
1.6.1.1 Contract Pharmaceutical Manufacturing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Contract Pharmaceutical Manufacturing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Contract Pharmaceutical Manufacturing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Contract Pharmaceutical Manufacturing Market Size Estimates and Forecasts
2.1.1 Global Contract Pharmaceutical Manufacturing Revenue 2015-2026
2.1.2 Global Contract Pharmaceutical Manufacturing Sales 2015-2026
2.2 Contract Pharmaceutical Manufacturing Market Size by Region: 2020 Versus 2026
2.2.1 Global Contract Pharmaceutical Manufacturing Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Contract Pharmaceutical Manufacturing Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL CONTRACT PHARMACEUTICAL MANUFACTURING COMPETITOR LANDSCAPE BY PLAYERS
3.1 Contract Pharmaceutical Manufacturing Sales by Manufacturers
3.1.1 Contract Pharmaceutical Manufacturing Sales by Manufacturers (2015-2020)
3.1.2 Contract Pharmaceutical Manufacturing Sales Market Share by Manufacturers (2015-2020)
3.2 Contract Pharmaceutical Manufacturing Revenue by Manufacturers
3.2.1 Contract Pharmaceutical Manufacturing Revenue by Manufacturers (2015-2020)
3.2.2 Contract Pharmaceutical Manufacturing Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Contract Pharmaceutical Manufacturing Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Contract Pharmaceutical Manufacturing Revenue in 2019
3.2.5 Global Contract Pharmaceutical Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Contract Pharmaceutical Manufacturing Price by Manufacturers
3.4 Contract Pharmaceutical Manufacturing Manufacturing Base Distribution, Product Types
3.4.1 Contract Pharmaceutical Manufacturing Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Contract Pharmaceutical Manufacturing Product Type
3.4.3 Date of International Manufacturers Enter into Contract Pharmaceutical Manufacturing Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Contract Pharmaceutical Manufacturing Market Size by Type (2015-2020)
4.1.1 Global Contract Pharmaceutical Manufacturing Sales by Type (2015-2020)
4.1.2 Global Contract Pharmaceutical Manufacturing Revenue by Type (2015-2020)
4.1.3 Contract Pharmaceutical Manufacturing Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Contract Pharmaceutical Manufacturing Market Size Forecast by Type (2021-2026)
4.2.1 Global Contract Pharmaceutical Manufacturing Sales Forecast by Type (2021-2026)
4.2.2 Global Contract Pharmaceutical Manufacturing Revenue Forecast by Type (2021-2026)
4.2.3 Contract Pharmaceutical Manufacturing Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Contract Pharmaceutical Manufacturing Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Contract Pharmaceutical Manufacturing Market Size by Application (2015-2020)
5.1.1 Global Contract Pharmaceutical Manufacturing Sales by Application (2015-2020)
5.1.2 Global Contract Pharmaceutical Manufacturing Revenue by Application (2015-2020)
5.1.3 Contract Pharmaceutical Manufacturing Price by Application (2015-2020)
5.2 Contract Pharmaceutical Manufacturing Market Size Forecast by Application (2021-2026)
5.2.1 Global Contract Pharmaceutical Manufacturing Sales Forecast by Application (2021-2026)
5.2.2 Global Contract Pharmaceutical Manufacturing Revenue Forecast by Application (2021-2026)
5.2.3 Global Contract Pharmaceutical Manufacturing Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Contract Pharmaceutical Manufacturing by Country
6.1.1 North America Contract Pharmaceutical Manufacturing Sales by Country
6.1.2 North America Contract Pharmaceutical Manufacturing Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Contract Pharmaceutical Manufacturing Market Facts & Figures by Type
6.3 North America Contract Pharmaceutical Manufacturing Market Facts & Figures by Application
7 EUROPE
7.1 Europe Contract Pharmaceutical Manufacturing by Country
7.1.1 Europe Contract Pharmaceutical Manufacturing Sales by Country
7.1.2 Europe Contract Pharmaceutical Manufacturing Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Contract Pharmaceutical Manufacturing Market Facts & Figures by Type
7.3 Europe Contract Pharmaceutical Manufacturing Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Contract Pharmaceutical Manufacturing by Region
8.1.1 Asia Pacific Contract Pharmaceutical Manufacturing Sales by Region
8.1.2 Asia Pacific Contract Pharmaceutical Manufacturing Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Contract Pharmaceutical Manufacturing Market Facts & Figures by Type
8.3 Asia Pacific Contract Pharmaceutical Manufacturing Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Contract Pharmaceutical Manufacturing by Country
9.1.1 Latin America Contract Pharmaceutical Manufacturing Sales by Country
9.1.2 Latin America Contract Pharmaceutical Manufacturing Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Contract Pharmaceutical Manufacturing Market Facts & Figures by Type
9.3 Central & South America Contract Pharmaceutical Manufacturing Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Contract Pharmaceutical Manufacturing by Country
10.1.1 Middle East and Africa Contract Pharmaceutical Manufacturing Sales by Country
10.1.2 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Contract Pharmaceutical Manufacturing Market Facts & Figures by Type
10.3 Middle East and Africa Contract Pharmaceutical Manufacturing Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Catalent
11.1.1 Catalent Corporation Information
11.1.2 Catalent Description, Business Overview and Total Revenue
11.1.3 Catalent Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Catalent Contract Pharmaceutical Manufacturing Products Offered
11.1.5 Catalent Recent Development
11.2 DPx
11.2.1 DPx Corporation Information
11.2.2 DPx Description, Business Overview and Total Revenue
11.2.3 DPx Sales, Revenue and Gross Margin (2015-2020)
11.2.4 DPx Contract Pharmaceutical Manufacturing Products Offered
11.2.5 DPx Recent Development
11.3 Lonza
11.3.1 Lonza Corporation Information
11.3.2 Lonza Description, Business Overview and Total Revenue
11.3.3 Lonza Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Lonza Contract Pharmaceutical Manufacturing Products Offered
11.3.5 Lonza Recent Development
11.4 Piramal Healthcare
11.4.1 Piramal Healthcare Corporation Information
11.4.2 Piramal Healthcare Description, Business Overview and Total Revenue
11.4.3 Piramal Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Piramal Healthcare Contract Pharmaceutical Manufacturing Products Offered
11.4.5 Piramal Healthcare Recent Development
11.5 Aenova
11.5.1 Aenova Corporation Information
11.5.2 Aenova Description, Business Overview and Total Revenue
11.5.3 Aenova Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Aenova Contract Pharmaceutical Manufacturing Products Offered
11.5.5 Aenova Recent Development
11.6 Jubilant
11.6.1 Jubilant Corporation Information
11.6.2 Jubilant Description, Business Overview and Total Revenue
11.6.3 Jubilant Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Jubilant Contract Pharmaceutical Manufacturing Products Offered
11.6.5 Jubilant Recent Development
11.7 Famar
11.7.1 Famar Corporation Information
11.7.2 Famar Description, Business Overview and Total Revenue
11.7.3 Famar Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Famar Contract Pharmaceutical Manufacturing Products Offered
11.7.5 Famar Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Corporation Information
11.8.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.8.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Products Offered
11.8.5 Boehringer Ingelheim Recent Development
11.9 Fareva Holding
11.9.1 Fareva Holding Corporation Information
11.9.2 Fareva Holding Description, Business Overview and Total Revenue
11.9.3 Fareva Holding Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Fareva Holding Contract Pharmaceutical Manufacturing Products Offered
11.9.5 Fareva Holding Recent Development
11.10 AbbVie
11.10.1 AbbVie Corporation Information
11.10.2 AbbVie Description, Business Overview and Total Revenue
11.10.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.10.4 AbbVie Contract Pharmaceutical Manufacturing Products Offered
11.10.5 AbbVie Recent Development
11.1 Catalent
11.1.1 Catalent Corporation Information
11.1.2 Catalent Description, Business Overview and Total Revenue
11.1.3 Catalent Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Catalent Contract Pharmaceutical Manufacturing Products Offered
11.1.5 Catalent Recent Development
11.12 Vetter
11.12.1 Vetter Corporation Information
11.12.2 Vetter Description, Business Overview and Total Revenue
11.12.3 Vetter Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Vetter Products Offered
11.12.5 Vetter Recent Development
11.13 Sopharma
11.13.1 Sopharma Corporation Information
11.13.2 Sopharma Description, Business Overview and Total Revenue
11.13.3 Sopharma Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Sopharma Products Offered
11.13.5 Sopharma Recent Development
11.14 DPT Laboratories
11.14.1 DPT Laboratories Corporation Information
11.14.2 DPT Laboratories Description, Business Overview and Total Revenue
11.14.3 DPT Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.14.4 DPT Laboratories Products Offered
11.14.5 DPT Laboratories Recent Development
11.15 Recipharm
11.15.1 Recipharm Corporation Information
11.15.2 Recipharm Description, Business Overview and Total Revenue
11.15.3 Recipharm Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Recipharm Products Offered
11.15.5 Recipharm Recent Development
11.16 NextPharma
11.16.1 NextPharma Corporation Information
11.16.2 NextPharma Description, Business Overview and Total Revenue
11.16.3 NextPharma Sales, Revenue and Gross Margin (2015-2020)
11.16.4 NextPharma Products Offered
11.16.5 NextPharma Recent Development
11.17 Dishman
11.17.1 Dishman Corporation Information
11.17.2 Dishman Description, Business Overview and Total Revenue
11.17.3 Dishman Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Dishman Products Offered
11.17.5 Dishman Recent Development
11.18 Aesica
11.18.1 Aesica Corporation Information
11.18.2 Aesica Description, Business Overview and Total Revenue
11.18.3 Aesica Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Aesica Products Offered
11.18.5 Aesica Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Contract Pharmaceutical Manufacturing Market Estimates and Projections by Region
12.1.1 Global Contract Pharmaceutical Manufacturing Sales Forecast by Regions 2021-2026
12.1.2 Global Contract Pharmaceutical Manufacturing Revenue Forecast by Regions 2021-2026
12.2 North America Contract Pharmaceutical Manufacturing Market Size Forecast (2021-2026)
12.2.1 North America: Contract Pharmaceutical Manufacturing Sales Forecast (2021-2026)
12.2.2 North America: Contract Pharmaceutical Manufacturing Revenue Forecast (2021-2026)
12.2.3 North America: Contract Pharmaceutical Manufacturing Market Size Forecast by Country (2021-2026)
12.3 Europe Contract Pharmaceutical Manufacturing Market Size Forecast (2021-2026)
12.3.1 Europe: Contract Pharmaceutical Manufacturing Sales Forecast (2021-2026)
12.3.2 Europe: Contract Pharmaceutical Manufacturing Revenue Forecast (2021-2026)
12.3.3 Europe: Contract Pharmaceutical Manufacturing Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Contract Pharmaceutical Manufacturing Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Contract Pharmaceutical Manufacturing Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Contract Pharmaceutical Manufacturing Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Contract Pharmaceutical Manufacturing Market Size Forecast by Region (2021-2026)
12.5 Latin America Contract Pharmaceutical Manufacturing Market Size Forecast (2021-2026)
12.5.1 Latin America: Contract Pharmaceutical Manufacturing Sales Forecast (2021-2026)
12.5.2 Latin America: Contract Pharmaceutical Manufacturing Revenue Forecast (2021-2026)
12.5.3 Latin America: Contract Pharmaceutical Manufacturing Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Contract Pharmaceutical Manufacturing Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Contract Pharmaceutical Manufacturing Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Contract Pharmaceutical Manufacturing Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Contract Pharmaceutical Manufacturing Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Contract Pharmaceutical Manufacturing Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Contract Pharmaceutical Manufacturing Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Contract Pharmaceutical Manufacturing Market Segments
Table 2. Ranking of Global Top Contract Pharmaceutical Manufacturing Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of API
Table 5. Major Manufacturers of FDF
Table 6. COVID-19 Impact Global Market: (Four Contract Pharmaceutical Manufacturing Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Contract Pharmaceutical Manufacturing Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Contract Pharmaceutical Manufacturing Players to Combat Covid-19 Impact
Table 11. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Contract Pharmaceutical Manufacturing Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Contract Pharmaceutical Manufacturing Sales by Regions 2015-2020 (K Units)
Table 14. Global Contract Pharmaceutical Manufacturing Sales Market Share by Regions (2015-2020)
Table 15. Global Contract Pharmaceutical Manufacturing Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Contract Pharmaceutical Manufacturing Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Contract Pharmaceutical Manufacturing Sales Share by Manufacturers (2015-2020)
Table 18. Global Contract Pharmaceutical Manufacturing Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Contract Pharmaceutical Manufacturing by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Contract Pharmaceutical Manufacturing as of 2019)
Table 20. Contract Pharmaceutical Manufacturing Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Contract Pharmaceutical Manufacturing Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Contract Pharmaceutical Manufacturing Price (2015-2020) (USD/Unit)
Table 23. Contract Pharmaceutical Manufacturing Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Contract Pharmaceutical Manufacturing Product Type
Table 25. Date of International Manufacturers Enter into Contract Pharmaceutical Manufacturing Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Contract Pharmaceutical Manufacturing Sales by Type (2015-2020) (K Units)
Table 28. Global Contract Pharmaceutical Manufacturing Sales Share by Type (2015-2020)
Table 29. Global Contract Pharmaceutical Manufacturing Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Contract Pharmaceutical Manufacturing Revenue Share by Type (2015-2020)
Table 31. Contract Pharmaceutical Manufacturing Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Contract Pharmaceutical Manufacturing Sales by Application (2015-2020) (K Units)
Table 33. Global Contract Pharmaceutical Manufacturing Sales Share by Application (2015-2020)
Table 34. North America Contract Pharmaceutical Manufacturing Sales by Country (2015-2020) (K Units)
Table 35. North America Contract Pharmaceutical Manufacturing Sales Market Share by Country (2015-2020)
Table 36. North America Contract Pharmaceutical Manufacturing Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Contract Pharmaceutical Manufacturing Revenue Market Share by Country (2015-2020)
Table 38. North America Contract Pharmaceutical Manufacturing Sales by Type (2015-2020) (K Units)
Table 39. North America Contract Pharmaceutical Manufacturing Sales Market Share by Type (2015-2020)
Table 40. North America Contract Pharmaceutical Manufacturing Sales by Application (2015-2020) (K Units)
Table 41. North America Contract Pharmaceutical Manufacturing Sales Market Share by Application (2015-2020)
Table 42. Europe Contract Pharmaceutical Manufacturing Sales by Country (2015-2020) (K Units)
Table 43. Europe Contract Pharmaceutical Manufacturing Sales Market Share by Country (2015-2020)
Table 44. Europe Contract Pharmaceutical Manufacturing Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Contract Pharmaceutical Manufacturing Revenue Market Share by Country (2015-2020)
Table 46. Europe Contract Pharmaceutical Manufacturing Sales by Type (2015-2020) (K Units)
Table 47. Europe Contract Pharmaceutical Manufacturing Sales Market Share by Type (2015-2020)
Table 48. Europe Contract Pharmaceutical Manufacturing Sales by Application (2015-2020) (K Units)
Table 49. Europe Contract Pharmaceutical Manufacturing Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Contract Pharmaceutical Manufacturing Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Contract Pharmaceutical Manufacturing Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Contract Pharmaceutical Manufacturing Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Contract Pharmaceutical Manufacturing Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Contract Pharmaceutical Manufacturing Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Contract Pharmaceutical Manufacturing Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Contract Pharmaceutical Manufacturing Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Contract Pharmaceutical Manufacturing Sales Market Share by Application (2015-2020)
Table 58. Latin America Contract Pharmaceutical Manufacturing Sales by Country (2015-2020) (K Units)
Table 59. Latin America Contract Pharmaceutical Manufacturing Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Contract Pharmaceutical Manufacturing Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Contract Pharmaceutical Manufacturing Revenue Market Share by Country (2015-2020)
Table 62. Latin America Contract Pharmaceutical Manufacturing Sales by Type (2015-2020) (K Units)
Table 63. Latin America Contract Pharmaceutical Manufacturing Sales Market Share by Type (2015-2020)
Table 64. Latin America Contract Pharmaceutical Manufacturing Sales by Application (2015-2020) (K Units)
Table 65. Latin America Contract Pharmaceutical Manufacturing Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Contract Pharmaceutical Manufacturing Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Contract Pharmaceutical Manufacturing Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Contract Pharmaceutical Manufacturing Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Contract Pharmaceutical Manufacturing Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Contract Pharmaceutical Manufacturing Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Contract Pharmaceutical Manufacturing Sales Market Share by Application (2015-2020)
Table 74. Catalent Corporation Information
Table 75. Catalent Description and Major Businesses
Table 76. Catalent Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Catalent Product
Table 78. Catalent Recent Development
Table 79. DPx Corporation Information
Table 80. DPx Description and Major Businesses
Table 81. DPx Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. DPx Product
Table 83. DPx Recent Development
Table 84. Lonza Corporation Information
Table 85. Lonza Description and Major Businesses
Table 86. Lonza Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Lonza Product
Table 88. Lonza Recent Development
Table 89. Piramal Healthcare Corporation Information
Table 90. Piramal Healthcare Description and Major Businesses
Table 91. Piramal Healthcare Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Piramal Healthcare Product
Table 93. Piramal Healthcare Recent Development
Table 94. Aenova Corporation Information
Table 95. Aenova Description and Major Businesses
Table 96. Aenova Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Aenova Product
Table 98. Aenova Recent Development
Table 99. Jubilant Corporation Information
Table 100. Jubilant Description and Major Businesses
Table 101. Jubilant Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Jubilant Product
Table 103. Jubilant Recent Development
Table 104. Famar Corporation Information
Table 105. Famar Description and Major Businesses
Table 106. Famar Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Famar Product
Table 108. Famar Recent Development
Table 109. Boehringer Ingelheim Corporation Information
Table 110. Boehringer Ingelheim Description and Major Businesses
Table 111. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Boehringer Ingelheim Product
Table 113. Boehringer Ingelheim Recent Development
Table 114. Fareva Holding Corporation Information
Table 115. Fareva Holding Description and Major Businesses
Table 116. Fareva Holding Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Fareva Holding Product
Table 118. Fareva Holding Recent Development
Table 119. AbbVie Corporation Information
Table 120. AbbVie Description and Major Businesses
Table 121. AbbVie Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. AbbVie Product
Table 123. AbbVie Recent Development
Table 124. Nipro Corp Corporation Information
Table 125. Nipro Corp Description and Major Businesses
Table 126. Nipro Corp Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Nipro Corp Product
Table 128. Nipro Corp Recent Development
Table 129. Vetter Corporation Information
Table 130. Vetter Description and Major Businesses
Table 131. Vetter Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Vetter Product
Table 133. Vetter Recent Development
Table 134. Sopharma Corporation Information
Table 135. Sopharma Description and Major Businesses
Table 136. Sopharma Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Sopharma Product
Table 138. Sopharma Recent Development
Table 139. DPT Laboratories Corporation Information
Table 140. DPT Laboratories Description and Major Businesses
Table 141. DPT Laboratories Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. DPT Laboratories Product
Table 143. DPT Laboratories Recent Development
Table 144. Recipharm Corporation Information
Table 145. Recipharm Description and Major Businesses
Table 146. Recipharm Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. Recipharm Product
Table 148. Recipharm Recent Development
Table 149. NextPharma Corporation Information
Table 150. NextPharma Description and Major Businesses
Table 151. NextPharma Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. NextPharma Product
Table 153. NextPharma Recent Development
Table 154. Dishman Corporation Information
Table 155. Dishman Description and Major Businesses
Table 156. Dishman Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 157. Dishman Product
Table 158. Dishman Recent Development
Table 159. Aesica Corporation Information
Table 160. Aesica Description and Major Businesses
Table 161. Aesica Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 162. Aesica Product
Table 163. Aesica Recent Development
Table 164. Global Contract Pharmaceutical Manufacturing Sales Forecast by Regions (2021-2026) (K Units)
Table 165. Global Contract Pharmaceutical Manufacturing Sales Market Share Forecast by Regions (2021-2026)
Table 166. Global Contract Pharmaceutical Manufacturing Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 167. Global Contract Pharmaceutical Manufacturing Revenue Market Share Forecast by Regions (2021-2026)
Table 168. North America: Contract Pharmaceutical Manufacturing Sales Forecast by Country (2021-2026) (K Units)
Table 169. North America: Contract Pharmaceutical Manufacturing Revenue Forecast by Country (2021-2026) (US$ Million)
Table 170. Europe: Contract Pharmaceutical Manufacturing Sales Forecast by Country (2021-2026) (K Units)
Table 171. Europe: Contract Pharmaceutical Manufacturing Revenue Forecast by Country (2021-2026) (US$ Million)
Table 172. Asia Pacific: Contract Pharmaceutical Manufacturing Sales Forecast by Region (2021-2026) (K Units)
Table 173. Asia Pacific: Contract Pharmaceutical Manufacturing Revenue Forecast by Region (2021-2026) (US$ Million)
Table 174. Latin America: Contract Pharmaceutical Manufacturing Sales Forecast by Country (2021-2026) (K Units)
Table 175. Latin America: Contract Pharmaceutical Manufacturing Revenue Forecast by Country (2021-2026) (US$ Million)
Table 176. Middle East and Africa: Contract Pharmaceutical Manufacturing Sales Forecast by Country (2021-2026) (K Units)
Table 177. Middle East and Africa: Contract Pharmaceutical Manufacturing Revenue Forecast by Country (2021-2026) (US$ Million)
Table 178. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 179. Key Challenges
Table 180. Market Risks
Table 181. Main Points Interviewed from Key Contract Pharmaceutical Manufacturing Players
Table 182. Contract Pharmaceutical Manufacturing Customers List
Table 183. Contract Pharmaceutical Manufacturing Distributors List
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
Table 1. Contract Pharmaceutical Manufacturing Market Segments
Table 2. Ranking of Global Top Contract Pharmaceutical Manufacturing Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of API
Table 5. Major Manufacturers of FDF
Table 6. COVID-19 Impact Global Market: (Four Contract Pharmaceutical Manufacturing Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Contract Pharmaceutical Manufacturing Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Contract Pharmaceutical Manufacturing Players to Combat Covid-19 Impact
Table 11. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Contract Pharmaceutical Manufacturing Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Contract Pharmaceutical Manufacturing Sales by Regions 2015-2020 (K Units)
Table 14. Global Contract Pharmaceutical Manufacturing Sales Market Share by Regions (2015-2020)
Table 15. Global Contract Pharmaceutical Manufacturing Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Contract Pharmaceutical Manufacturing Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Contract Pharmaceutical Manufacturing Sales Share by Manufacturers (2015-2020)
Table 18. Global Contract Pharmaceutical Manufacturing Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Contract Pharmaceutical Manufacturing by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Contract Pharmaceutical Manufacturing as of 2019)
Table 20. Contract Pharmaceutical Manufacturing Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Contract Pharmaceutical Manufacturing Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Contract Pharmaceutical Manufacturing Price (2015-2020) (USD/Unit)
Table 23. Contract Pharmaceutical Manufacturing Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Contract Pharmaceutical Manufacturing Product Type
Table 25. Date of International Manufacturers Enter into Contract Pharmaceutical Manufacturing Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Contract Pharmaceutical Manufacturing Sales by Type (2015-2020) (K Units)
Table 28. Global Contract Pharmaceutical Manufacturing Sales Share by Type (2015-2020)
Table 29. Global Contract Pharmaceutical Manufacturing Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Contract Pharmaceutical Manufacturing Revenue Share by Type (2015-2020)
Table 31. Contract Pharmaceutical Manufacturing Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Contract Pharmaceutical Manufacturing Sales by Application (2015-2020) (K Units)
Table 33. Global Contract Pharmaceutical Manufacturing Sales Share by Application (2015-2020)
Table 34. North America Contract Pharmaceutical Manufacturing Sales by Country (2015-2020) (K Units)
Table 35. North America Contract Pharmaceutical Manufacturing Sales Market Share by Country (2015-2020)
Table 36. North America Contract Pharmaceutical Manufacturing Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Contract Pharmaceutical Manufacturing Revenue Market Share by Country (2015-2020)
Table 38. North America Contract Pharmaceutical Manufacturing Sales by Type (2015-2020) (K Units)
Table 39. North America Contract Pharmaceutical Manufacturing Sales Market Share by Type (2015-2020)
Table 40. North America Contract Pharmaceutical Manufacturing Sales by Application (2015-2020) (K Units)
Table 41. North America Contract Pharmaceutical Manufacturing Sales Market Share by Application (2015-2020)
Table 42. Europe Contract Pharmaceutical Manufacturing Sales by Country (2015-2020) (K Units)
Table 43. Europe Contract Pharmaceutical Manufacturing Sales Market Share by Country (2015-2020)
Table 44. Europe Contract Pharmaceutical Manufacturing Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Contract Pharmaceutical Manufacturing Revenue Market Share by Country (2015-2020)
Table 46. Europe Contract Pharmaceutical Manufacturing Sales by Type (2015-2020) (K Units)
Table 47. Europe Contract Pharmaceutical Manufacturing Sales Market Share by Type (2015-2020)
Table 48. Europe Contract Pharmaceutical Manufacturing Sales by Application (2015-2020) (K Units)
Table 49. Europe Contract Pharmaceutical Manufacturing Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Contract Pharmaceutical Manufacturing Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Contract Pharmaceutical Manufacturing Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Contract Pharmaceutical Manufacturing Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Contract Pharmaceutical Manufacturing Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Contract Pharmaceutical Manufacturing Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Contract Pharmaceutical Manufacturing Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Contract Pharmaceutical Manufacturing Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Contract Pharmaceutical Manufacturing Sales Market Share by Application (2015-2020)
Table 58. Latin America Contract Pharmaceutical Manufacturing Sales by Country (2015-2020) (K Units)
Table 59. Latin America Contract Pharmaceutical Manufacturing Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Contract Pharmaceutical Manufacturing Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Contract Pharmaceutical Manufacturing Revenue Market Share by Country (2015-2020)
Table 62. Latin America Contract Pharmaceutical Manufacturing Sales by Type (2015-2020) (K Units)
Table 63. Latin America Contract Pharmaceutical Manufacturing Sales Market Share by Type (2015-2020)
Table 64. Latin America Contract Pharmaceutical Manufacturing Sales by Application (2015-2020) (K Units)
Table 65. Latin America Contract Pharmaceutical Manufacturing Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Contract Pharmaceutical Manufacturing Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Contract Pharmaceutical Manufacturing Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Contract Pharmaceutical Manufacturing Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Contract Pharmaceutical Manufacturing Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Contract Pharmaceutical Manufacturing Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Contract Pharmaceutical Manufacturing Sales Market Share by Application (2015-2020)
Table 74. Catalent Corporation Information
Table 75. Catalent Description and Major Businesses
Table 76. Catalent Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Catalent Product
Table 78. Catalent Recent Development
Table 79. DPx Corporation Information
Table 80. DPx Description and Major Businesses
Table 81. DPx Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. DPx Product
Table 83. DPx Recent Development
Table 84. Lonza Corporation Information
Table 85. Lonza Description and Major Businesses
Table 86. Lonza Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Lonza Product
Table 88. Lonza Recent Development
Table 89. Piramal Healthcare Corporation Information
Table 90. Piramal Healthcare Description and Major Businesses
Table 91. Piramal Healthcare Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Piramal Healthcare Product
Table 93. Piramal Healthcare Recent Development
Table 94. Aenova Corporation Information
Table 95. Aenova Description and Major Businesses
Table 96. Aenova Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Aenova Product
Table 98. Aenova Recent Development
Table 99. Jubilant Corporation Information
Table 100. Jubilant Description and Major Businesses
Table 101. Jubilant Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Jubilant Product
Table 103. Jubilant Recent Development
Table 104. Famar Corporation Information
Table 105. Famar Description and Major Businesses
Table 106. Famar Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Famar Product
Table 108. Famar Recent Development
Table 109. Boehringer Ingelheim Corporation Information
Table 110. Boehringer Ingelheim Description and Major Businesses
Table 111. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Boehringer Ingelheim Product
Table 113. Boehringer Ingelheim Recent Development
Table 114. Fareva Holding Corporation Information
Table 115. Fareva Holding Description and Major Businesses
Table 116. Fareva Holding Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Fareva Holding Product
Table 118. Fareva Holding Recent Development
Table 119. AbbVie Corporation Information
Table 120. AbbVie Description and Major Businesses
Table 121. AbbVie Contract Pharmaceutical Manufacturing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. AbbVie Product
Table 123. AbbVie Recent Development
Table 124. Nipro Corp Corporation Information
Table 125. Nipro Corp Description and Major Businesses
Table 126. Nipro Corp Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Nipro Corp Product
Table 128. Nipro Corp Recent Development
Table 129. Vetter Corporation Information
Table 130. Vetter Description and Major Businesses
Table 131. Vetter Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Vetter Product
Table 133. Vetter Recent Development
Table 134. Sopharma Corporation Information
Table 135. Sopharma Description and Major Businesses
Table 136. Sopharma Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Sopharma Product
Table 138. Sopharma Recent Development
Table 139. DPT Laboratories Corporation Information
Table 140. DPT Laboratories Description and Major Businesses
Table 141. DPT Laboratories Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. DPT Laboratories Product
Table 143. DPT Laboratories Recent Development
Table 144. Recipharm Corporation Information
Table 145. Recipharm Description and Major Businesses
Table 146. Recipharm Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. Recipharm Product
Table 148. Recipharm Recent Development
Table 149. NextPharma Corporation Information
Table 150. NextPharma Description and Major Businesses
Table 151. NextPharma Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. NextPharma Product
Table 153. NextPharma Recent Development
Table 154. Dishman Corporation Information
Table 155. Dishman Description and Major Businesses
Table 156. Dishman Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 157. Dishman Product
Table 158. Dishman Recent Development
Table 159. Aesica Corporation Information
Table 160. Aesica Description and Major Businesses
Table 161. Aesica Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 162. Aesica Product
Table 163. Aesica Recent Development
Table 164. Global Contract Pharmaceutical Manufacturing Sales Forecast by Regions (2021-2026) (K Units)
Table 165. Global Contract Pharmaceutical Manufacturing Sales Market Share Forecast by Regions (2021-2026)
Table 166. Global Contract Pharmaceutical Manufacturing Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 167. Global Contract Pharmaceutical Manufacturing Revenue Market Share Forecast by Regions (2021-2026)
Table 168. North America: Contract Pharmaceutical Manufacturing Sales Forecast by Country (2021-2026) (K Units)
Table 169. North America: Contract Pharmaceutical Manufacturing Revenue Forecast by Country (2021-2026) (US$ Million)
Table 170. Europe: Contract Pharmaceutical Manufacturing Sales Forecast by Country (2021-2026) (K Units)
Table 171. Europe: Contract Pharmaceutical Manufacturing Revenue Forecast by Country (2021-2026) (US$ Million)
Table 172. Asia Pacific: Contract Pharmaceutical Manufacturing Sales Forecast by Region (2021-2026) (K Units)
Table 173. Asia Pacific: Contract Pharmaceutical Manufacturing Revenue Forecast by Region (2021-2026) (US$ Million)
Table 174. Latin America: Contract Pharmaceutical Manufacturing Sales Forecast by Country (2021-2026) (K Units)
Table 175. Latin America: Contract Pharmaceutical Manufacturing Revenue Forecast by Country (2021-2026) (US$ Million)
Table 176. Middle East and Africa: Contract Pharmaceutical Manufacturing Sales Forecast by Country (2021-2026) (K Units)
Table 177. Middle East and Africa: Contract Pharmaceutical Manufacturing Revenue Forecast by Country (2021-2026) (US$ Million)
Table 178. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 179. Key Challenges
Table 180. Market Risks
Table 181. Main Points Interviewed from Key Contract Pharmaceutical Manufacturing Players
Table 182. Contract Pharmaceutical Manufacturing Customers List
Table 183. Contract Pharmaceutical Manufacturing Distributors List
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Contract Pharmaceutical Manufacturing Product Picture
Figure 2. Global Contract Pharmaceutical Manufacturing Sales Market Share by Type in 2020 & 2026
Figure 3. API Product Picture
Figure 4. FDF Product Picture
Figure 5. Global Contract Pharmaceutical Manufacturing Sales Market Share by Application in 2020 & 2026
Figure 6. Specialty/Midsize
Figure 7. Generics
Figure 8. Big Pharma
Figure 9. Other
Figure 10. Contract Pharmaceutical Manufacturing Report Years Considered
Figure 11. Global Contract Pharmaceutical Manufacturing Market Size 2015-2026 (US$ Million)
Figure 12. Global Contract Pharmaceutical Manufacturing Sales 2015-2026 (K Units)
Figure 13. Global Contract Pharmaceutical Manufacturing Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Contract Pharmaceutical Manufacturing Sales Market Share by Region (2015-2020)
Figure 15. Global Contract Pharmaceutical Manufacturing Sales Market Share by Region in 2019
Figure 16. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Region (2015-2020)
Figure 17. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Region in 2019
Figure 18. Global Contract Pharmaceutical Manufacturing Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Contract Pharmaceutical Manufacturing Revenue in 2019
Figure 20. Contract Pharmaceutical Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Contract Pharmaceutical Manufacturing Sales Market Share by Type (2015-2020)
Figure 22. Global Contract Pharmaceutical Manufacturing Sales Market Share by Type in 2019
Figure 23. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2015-2020)
Figure 24. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type in 2019
Figure 25. Global Contract Pharmaceutical Manufacturing Market Share by Price Range (2015-2020)
Figure 26. Global Contract Pharmaceutical Manufacturing Sales Market Share by Application (2015-2020)
Figure 27. Global Contract Pharmaceutical Manufacturing Sales Market Share by Application in 2019
Figure 28. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2015-2020)
Figure 29. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application in 2019
Figure 30. North America Contract Pharmaceutical Manufacturing Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Contract Pharmaceutical Manufacturing Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Contract Pharmaceutical Manufacturing Sales Market Share by Country in 2019
Figure 33. North America Contract Pharmaceutical Manufacturing Revenue Market Share by Country in 2019
Figure 34. U.S. Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Contract Pharmaceutical Manufacturing Market Share by Type in 2019
Figure 39. North America Contract Pharmaceutical Manufacturing Market Share by Application in 2019
Figure 40. Europe Contract Pharmaceutical Manufacturing Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Contract Pharmaceutical Manufacturing Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Contract Pharmaceutical Manufacturing Sales Market Share by Country in 2019
Figure 43. Europe Contract Pharmaceutical Manufacturing Revenue Market Share by Country in 2019
Figure 44. Germany Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Contract Pharmaceutical Manufacturing Market Share by Type in 2019
Figure 55. Europe Contract Pharmaceutical Manufacturing Market Share by Application in 2019
Figure 56. Asia Pacific Contract Pharmaceutical Manufacturing Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Contract Pharmaceutical Manufacturing Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Contract Pharmaceutical Manufacturing Sales Market Share by Region in 2019
Figure 59. Asia Pacific Contract Pharmaceutical Manufacturing Revenue Market Share by Region in 2019
Figure 60. China Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Contract Pharmaceutical Manufacturing Market Share by Type in 2019
Figure 83. Asia Pacific Contract Pharmaceutical Manufacturing Market Share by Application in 2019
Figure 84. Latin America Contract Pharmaceutical Manufacturing Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Contract Pharmaceutical Manufacturing Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Contract Pharmaceutical Manufacturing Sales Market Share by Country in 2019
Figure 87. Latin America Contract Pharmaceutical Manufacturing Revenue Market Share by Country in 2019
Figure 88. Mexico Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Contract Pharmaceutical Manufacturing Market Share by Type in 2019
Figure 95. Latin America Contract Pharmaceutical Manufacturing Market Share by Application in 2019
Figure 96. Middle East and Africa Contract Pharmaceutical Manufacturing Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Contract Pharmaceutical Manufacturing Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Market Share by Country in 2019
Figure 100. Turkey Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. UAE Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 105. UAE Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Contract Pharmaceutical Manufacturing Market Share by Type in 2019
Figure 107. Middle East and Africa Contract Pharmaceutical Manufacturing Market Share by Application in 2019
Figure 108. Catalent Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. DPx Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Piramal Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Aenova Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Jubilant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Famar Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Fareva Holding Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Nipro Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Vetter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Sopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. DPT Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Recipharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. NextPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Dishman Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. Aesica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 126. North America Contract Pharmaceutical Manufacturing Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 127. North America Contract Pharmaceutical Manufacturing Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Europe Contract Pharmaceutical Manufacturing Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 129. Europe Contract Pharmaceutical Manufacturing Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Asia Pacific Contract Pharmaceutical Manufacturing Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 131. Asia Pacific Contract Pharmaceutical Manufacturing Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Latin America Contract Pharmaceutical Manufacturing Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 133. Latin America Contract Pharmaceutical Manufacturing Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 134. Middle East and Africa Contract Pharmaceutical Manufacturing Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 135. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 136. Porter's Five Forces Analysis
Figure 137. Channels of Distribution
Figure 138. Distributors Profiles
Figure 139. Bottom-up and Top-down Approaches for This Report
Figure 140. Data Triangulation
Figure 141. Key Executives Interviewed
Figure 1. Contract Pharmaceutical Manufacturing Product Picture
Figure 2. Global Contract Pharmaceutical Manufacturing Sales Market Share by Type in 2020 & 2026
Figure 3. API Product Picture
Figure 4. FDF Product Picture
Figure 5. Global Contract Pharmaceutical Manufacturing Sales Market Share by Application in 2020 & 2026
Figure 6. Specialty/Midsize
Figure 7. Generics
Figure 8. Big Pharma
Figure 9. Other
Figure 10. Contract Pharmaceutical Manufacturing Report Years Considered
Figure 11. Global Contract Pharmaceutical Manufacturing Market Size 2015-2026 (US$ Million)
Figure 12. Global Contract Pharmaceutical Manufacturing Sales 2015-2026 (K Units)
Figure 13. Global Contract Pharmaceutical Manufacturing Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Contract Pharmaceutical Manufacturing Sales Market Share by Region (2015-2020)
Figure 15. Global Contract Pharmaceutical Manufacturing Sales Market Share by Region in 2019
Figure 16. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Region (2015-2020)
Figure 17. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Region in 2019
Figure 18. Global Contract Pharmaceutical Manufacturing Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Contract Pharmaceutical Manufacturing Revenue in 2019
Figure 20. Contract Pharmaceutical Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Contract Pharmaceutical Manufacturing Sales Market Share by Type (2015-2020)
Figure 22. Global Contract Pharmaceutical Manufacturing Sales Market Share by Type in 2019
Figure 23. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2015-2020)
Figure 24. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type in 2019
Figure 25. Global Contract Pharmaceutical Manufacturing Market Share by Price Range (2015-2020)
Figure 26. Global Contract Pharmaceutical Manufacturing Sales Market Share by Application (2015-2020)
Figure 27. Global Contract Pharmaceutical Manufacturing Sales Market Share by Application in 2019
Figure 28. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2015-2020)
Figure 29. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application in 2019
Figure 30. North America Contract Pharmaceutical Manufacturing Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Contract Pharmaceutical Manufacturing Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Contract Pharmaceutical Manufacturing Sales Market Share by Country in 2019
Figure 33. North America Contract Pharmaceutical Manufacturing Revenue Market Share by Country in 2019
Figure 34. U.S. Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Contract Pharmaceutical Manufacturing Market Share by Type in 2019
Figure 39. North America Contract Pharmaceutical Manufacturing Market Share by Application in 2019
Figure 40. Europe Contract Pharmaceutical Manufacturing Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Contract Pharmaceutical Manufacturing Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Contract Pharmaceutical Manufacturing Sales Market Share by Country in 2019
Figure 43. Europe Contract Pharmaceutical Manufacturing Revenue Market Share by Country in 2019
Figure 44. Germany Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Contract Pharmaceutical Manufacturing Market Share by Type in 2019
Figure 55. Europe Contract Pharmaceutical Manufacturing Market Share by Application in 2019
Figure 56. Asia Pacific Contract Pharmaceutical Manufacturing Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Contract Pharmaceutical Manufacturing Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Contract Pharmaceutical Manufacturing Sales Market Share by Region in 2019
Figure 59. Asia Pacific Contract Pharmaceutical Manufacturing Revenue Market Share by Region in 2019
Figure 60. China Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Contract Pharmaceutical Manufacturing Market Share by Type in 2019
Figure 83. Asia Pacific Contract Pharmaceutical Manufacturing Market Share by Application in 2019
Figure 84. Latin America Contract Pharmaceutical Manufacturing Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Contract Pharmaceutical Manufacturing Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Contract Pharmaceutical Manufacturing Sales Market Share by Country in 2019
Figure 87. Latin America Contract Pharmaceutical Manufacturing Revenue Market Share by Country in 2019
Figure 88. Mexico Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Contract Pharmaceutical Manufacturing Market Share by Type in 2019
Figure 95. Latin America Contract Pharmaceutical Manufacturing Market Share by Application in 2019
Figure 96. Middle East and Africa Contract Pharmaceutical Manufacturing Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Contract Pharmaceutical Manufacturing Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Market Share by Country in 2019
Figure 100. Turkey Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. UAE Contract Pharmaceutical Manufacturing Sales Growth Rate (2015-2020) (K Units)
Figure 105. UAE Contract Pharmaceutical Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Contract Pharmaceutical Manufacturing Market Share by Type in 2019
Figure 107. Middle East and Africa Contract Pharmaceutical Manufacturing Market Share by Application in 2019
Figure 108. Catalent Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. DPx Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Piramal Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Aenova Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Jubilant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Famar Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Fareva Holding Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Nipro Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Vetter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Sopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. DPT Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Recipharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. NextPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Dishman Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. Aesica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 126. North America Contract Pharmaceutical Manufacturing Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 127. North America Contract Pharmaceutical Manufacturing Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Europe Contract Pharmaceutical Manufacturing Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 129. Europe Contract Pharmaceutical Manufacturing Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Asia Pacific Contract Pharmaceutical Manufacturing Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 131. Asia Pacific Contract Pharmaceutical Manufacturing Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Latin America Contract Pharmaceutical Manufacturing Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 133. Latin America Contract Pharmaceutical Manufacturing Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 134. Middle East and Africa Contract Pharmaceutical Manufacturing Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 135. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 136. Porter's Five Forces Analysis
Figure 137. Channels of Distribution
Figure 138. Distributors Profiles
Figure 139. Bottom-up and Top-down Approaches for This Report
Figure 140. Data Triangulation
Figure 141. Key Executives Interviewed
